Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
Our Research Team Covers 300 Companies Across 24 Sectors

STOCK RECOMMENDATION

Search a Stock
Sectors
Sort by
Sort by
Clear
  • Reco Date
  • Reco price
  • Earning growth
Reco Date
 Stock Name
 sector
 View
 Reco Price
 Earning Growth
(2 year expected CAGR)		 Forward P/E

The price to earnings ratio (P/E) measures the market’s valuation of a company relative to its annual net profits

 Read Report
Search a Stock
Sectors
Sort by
Sort by
Clear
  • Reco Date
  • Reco price
  • Exit Price
  • Exit Date
  • Returns
Reco Date
 Stock Name
 Sector
 Reco Price
 Exit Price
 Exit Date
 Last Recommendation
 Returns
Aug 22, 2022 Hikal Pharmaceuticals 315.00 279.35 Jul 26, 2023 overweight -11.32 %
Jul 3, 2019 Hikal Pharmaceuticals 169.00 514.00 Jan 11, 2022 overweight 204.14 %
Hikal
Pharmaceuticals
Reco Price (Aug 22, 2022) 315.00
Last Recommendation overweight
Exit Price (Jul 26, 2023) 279.35
Returns: -11.32 %
Hikal
Pharmaceuticals
Reco Price (Jul 3, 2019) 169.00
Last Recommendation overweight
Exit Price (Jan 11, 2022) 514.00
Returns: 204.14 %
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347